• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emergencias . Diagnostic groups and short-term outcomes in suspected COVID-19 cases treated in an emergency department

tetano

Editor, Senior Moderator
Emergencias


. 2020 Ago;32(4):242-252.

Diagnostic groups and short-term outcomes in suspected COVID-19 cases treated in an emergency department


[Article in Spanish, En]

F Javier Mart?n-S?nchez[SUP] 1 [/SUP], Juan Gonz?lez Del Castillo[SUP] 2 [/SUP], Adri?n Valls Carb?[SUP] 3 [/SUP], Amanda L?pez Picado[SUP] 4 [/SUP], Carmen Mart?nez-Valero[SUP] 4 [/SUP], Juande D Miranda[SUP] 5 [/SUP], Ana Chac?n[SUP] 6 [/SUP], Pedro L?pez-Ayala[SUP] 7 [/SUP], David Chaparro[SUP] 8 [/SUP], Gabriel Cozar L?pez[SUP] 8 [/SUP], Mar?a Del Mar Su?rez-Cadenas[SUP] 2 [/SUP], Pablo Jerez Fern?ndez[SUP] 8 [/SUP], Enrique Del Toro[SUP] 8 [/SUP], Eduardo Cardassay[SUP] 8 [/SUP], Beatriz Ang?s[SUP] 8 [/SUP], Cristina D?az Del Arco[SUP] 9 [/SUP], Esther Rodr?guez Adrada[SUP] 4 [/SUP], Mar?a Teresa Montalvo Moraleda[SUP] 3 [/SUP], Carolina Espejo Paeres[SUP] 10 [/SUP], Carlos Elvira[SUP] 6 [/SUP], Miguel ?ngel Garc?a Bri??n[SUP] 2 [/SUP], Jos? M? Leal Pozuelo[SUP] 11 [/SUP], Luis Ortega[SUP] 9 [/SUP], Cristina Fern?ndez P?rez[SUP] 12 [/SUP], Juan Jorge Gonz?lez Armengol[SUP] 1 [/SUP]



Affiliations
  • PMID: 32692001

Abstract

in En , Spanish
Objectives: The primary objective was to describe the clinical characteristics and 30-day mortality rates in emergency department patients with coronavirus disease 2019 (COVID-19) in different diagnostic groupings.
Material and methods: Secondary analysis of the COVID-19 registry compiled by the emergency department of Hospital Cl?nico San Carlos in Madrid, Spain. We selected suspected COVID-19 cases treated in the emergency department between February 28 and March 31, 2020. The cases were grouped as follows: 1) suspected, no polymerase chain reaction (PCR) test (S/no-PCR); 2) suspected, negative PCR (S/PCR-); 3) suspected, positive PCR (S/PCR+); 4) highly suspected, no PCR, or negative PCR (HS/no or PCR-); and 5) highly suspected, positive PCR (HS/PCR+). We collected clinical, radiologic, and microbiologic data related to the emergency visit. The main outcome was 30-day all-cause mortality. Secondary outcomes were hospitalization and clinical severity of the episode.
Results: A total of 1993 cases (90.9%) were included as follows: S/no-PCR, 17.2%; S/PCR-, 11.4%; S/PCR+, 22.1%; HS/no PCR or PCR-, 11.7%; and HS/PCR+, 37.6%. Short-term outcomes differed significantly in the different groups according to demographic characteristics; comorbidity and clinical, radiographic, analytical, and therapeutic variables. Thirty-day mortality was 11.5% (56.5% in hospitalized cases and 19.6% in cases classified as severe). The 2 HS categories and the S/PCR+ category had a greater adjusted risk for 30-day mortality and for having a clinically severe episode during hospitalization in comparison with S/PCR- cases. Only the 2 HS categories showed greater risk for hospitalization than the S/PCR- cases.
Conclusion: COVID-19 diagnostic groups differ according to clinical and laboratory characteristics, and the differences are associated with the 30-day prognosis.

Keywords: COVID-19; Emergency department; Mortalidad; Mortality; PCR; Polymerase chain reaction (PCR); SARS-CoV-2; SARS-Cov-2; Servicio de urgencias.
 
Back
Top Bottom